Biopharm Modeling Scientist: Dissolution & Formulation

100 Eli Lilly and Company; Indianapolis (IN); On-site; USD 65,000 - 149,000; Full time

Job summary

At Lilly, the Synthetic Molecule Design and Development (SMDD) group develops analytical methods and conducts experiments to enable early clinical formulation development for a broad range of drug molecules. The team collaborates with formulation scientists, analytical chemists, and engineers to determine optimal drug forms and formulations.

The role emphasizes identifying technical risks, adhering to GLP/GMP standards, and authoring key regulatory documents to support clinical trials and

Qualifications

• Bachelor-level science degree required.
• Experience with analytical techniques for drug substances and products.
• Strong leadership, teamwork, communication and writing skills.

Responsibilities

• Develop analytical methods and conduct experiments for early clinical formulation development.
• Collaborate with formulation scientists to design experiments and guide selection/characterization of formulations.
• Partner with biopharmaceutical modeling scientists and engineers to identify drug form, formulation and process characteristics.
• Identify and mitigate technical risks for performance and production of clinical and commercial products.
• Ensure compliance with safety, quality, regulatory, GLP/GMP and legal requirements.

Skills

Leadership

Communication

Writing skills

Teamwork

Analytical thinking

Education

B.S. in Chemistry/Biochemistry/Pharmaceutical Science

Tools

HPLC

UV

NIR

Dissolution

Job description

At Lilly, the Synthetic Molecule Design and Development (SMDD) group develops analytical methods and conducts experiments to enable early clinical formulation development for a broad range of drug molecules. The team collaborates with formulation scientists, analytical chemists, and engineers to determine optimal drug forms and formulations.

The role emphasizes identifying technical risks, adhering to GLP/GMP standards, and authoring key regulatory documents to support clinical trials and